Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin R Flaherty

Showing results (41-50 of 204) with videos related to

Pageof 21
Sort By:
American Journal of Respiratory and Critical Care Medicine|December 22, 2016
Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to GoMargaret L Salisbury, Jeffrey L Myers, Elizabeth A Belloli, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|September 17, 2008
Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlationAnil K Attili, Ella A Kazerooni, Barry H Gross, et al.
Frontiers in Immunology|September 1, 2022
B7H3-dependent myeloid-derived suppressor cell recruitment and activation in pulmonary fibrosisTianju Liu, Francina Gonzalez De Los Santos, Andrew E Rinke, et al.
The American Journal of Pathology|March 30, 2007
Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient miceElizabeth M Pierce, Kristin Carpenter, Claudia Jakubzick, et al.
American Journal of Respiratory and Critical Care Medicine|August 24, 2019
Which Biopsy to Diagnose Interstitial Lung Disease? A Call for Evidence and UnityLuca Richeldi, Vincent Cottin, Kevin K Brown, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 25, 2024
Results from randomized trial of pirfenidone in patients with chronic rejection (STOP-CLAD study)Michael P Combs, Elizabeth A Belloli, Nicolas Gargurevich, et al.
Advances in Therapy|September 26, 2023
Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline CharacteristicsMartin Kolb, Kevin R Flaherty, Rafael S Silva, et al.
American Journal of Respiratory and Critical Care Medicine|January 20, 2009
Interleukin-17-mediated immunopathogenesis in experimental hypersensitivity pneumonitisAmrita D Joshi, Daniel J Fong, Sameer R Oak, et al.
American Journal of Respiratory and Critical Care Medicine|January 31, 2009
Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosisAntje Prasse, Corinna Probst, Elena Bargagli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosisEric S White, Kevin R Flaherty, Shannon Carskadon, et al.
Pageof 21

Showing results (41-50 of 204) with videos related to

Sort By:
Pageof 21
American Journal of Respiratory and Critical Care Medicine|December 22, 2016
Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to GoMargaret L Salisbury, Jeffrey L Myers, Elizabeth A Belloli, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|September 17, 2008
Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlationAnil K Attili, Ella A Kazerooni, Barry H Gross, et al.
Frontiers in Immunology|September 1, 2022
B7H3-dependent myeloid-derived suppressor cell recruitment and activation in pulmonary fibrosisTianju Liu, Francina Gonzalez De Los Santos, Andrew E Rinke, et al.
The American Journal of Pathology|March 30, 2007
Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient miceElizabeth M Pierce, Kristin Carpenter, Claudia Jakubzick, et al.
American Journal of Respiratory and Critical Care Medicine|August 24, 2019
Which Biopsy to Diagnose Interstitial Lung Disease? A Call for Evidence and UnityLuca Richeldi, Vincent Cottin, Kevin K Brown, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 25, 2024
Results from randomized trial of pirfenidone in patients with chronic rejection (STOP-CLAD study)Michael P Combs, Elizabeth A Belloli, Nicolas Gargurevich, et al.
Advances in Therapy|September 26, 2023
Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline CharacteristicsMartin Kolb, Kevin R Flaherty, Rafael S Silva, et al.
American Journal of Respiratory and Critical Care Medicine|January 20, 2009
Interleukin-17-mediated immunopathogenesis in experimental hypersensitivity pneumonitisAmrita D Joshi, Daniel J Fong, Sameer R Oak, et al.
American Journal of Respiratory and Critical Care Medicine|January 31, 2009
Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosisAntje Prasse, Corinna Probst, Elena Bargagli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosisEric S White, Kevin R Flaherty, Shannon Carskadon, et al.
Pageof 21